Glial fibrillary acidic protein as a marker of axonal damage in chronic neuropathies

Muscle and Nerve

Volumn 40, Issue 1, 2009, Pages 50-54

  Notturno, Francesca ^a   Capasso, Margherita ^a   Delauretis, Angelo ^b   Carpo, Marinella ^c   Uncini, Antonino ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c IRCCS   (Italy)

Author keywords

Axonal damage; Chronic neuropathies; Disease severity; Glial fibrillary acidic protein

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC DISEASE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOTOR NEUROPATHY; NERVE FIBER; NERVE INJURY; NERVE POTENTIAL; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SENSORY NERVE; SENSORY NEUROPATHY; SPINAL CORD ATROPHY;

ADOLESCENT; ADULT; AXONS; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HEREDITARY MOTOR AND SENSORY NEUROPATHIES; HUMANS; MALE; MIDDLE AGED; POLYRADICULONEUROPATHY; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; ROC CURVE; SURAL NERVE; YOUNG ADULT;

EID: 67650252521     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21323     Document Type: Article

References (26)

1. Autilo-Gambetti L, Sipple J, Sudilowski O, Gambetti P. Intermediate filaments of Scwann cells. J Neurochem 1982;38:774-780.
2. Bianchini D, De Martini I, Cadoni A, Zicca A, Tabaton M, Schenone A, et al. GFAP expression of human Schwann cells in tissue culture. Brain Res 1992;20:209-217.
3. Brownell B, Oppenheimer DR, Hughes JT. The central nervous system in motor neurone disease. J Neurol Neurosurg Psychiatry 1970;33:338-357.
4. Dyck PJ, Giannini C, Lais A. Pathologic alteration of nerves. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy. Philadelphia: WB Saunders; 1993. p 514-595.
5. Fields K, Yen SH. A subset of Scwann cells in peripheral nerves contain a 50-kDa protein antigenically related to astrocyte intermediate filaments. J Neuroimmunol 1985;8:311-330. (Pubitemid 15025259)
6. Fujita K, Yamauchi M, Matsui T, Titani K, Takahashi H, Kato T, et al. Increase of glial fibrillary acidic protein fragments in the spinal cord of motor neuron degeneration mutant mouse. Brain Res 1998;785:31-34. (Pubitemid 28194751)
7. Graham RC, Hughes RA. A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. J Neurol Neurosurg Psychiatry 2006;77:973-976. (Pubitemid 44174089)
8. Herrmann M, Vos P, Wunderlich MT, de Bruijn CH, Lamers KJ. Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke 2000;31:2670-2677. (Pubitemid 30813062)
9. Hughes RAC, Bouche P, Cornblath DR, Evers E, Hadden RDM, Hahn A, et al. European Federation of Neurological Sciences/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 2006b;13:326-332.
10. Jacobs JM, Love S. Qualitative and quantitative morphology of human sural nerve at different ages. Brain 1985;108:897-924. (Pubitemid 16185408)
11. Jessen KR, Mirsky R. Non-myelin-forming Schwann cells coexpress surface proteins and intermediate filaments not found in myelin-forming cells: a study of Ran-2, A5E3, antigen and glial fibrillary acidic protein. J Neurocytol 1984;13:923-934.
12. Jessen KR, Mirski R. Schwann cells and their precursors emerge as major regulators of nerve development. Trends Neurosci 1999;22:402-410. (Pubitemid 29453645)
13. Mancardi GL, Cadoni A, Tabaton M, Schenone A, Zicca A, De Martini I, et al. Schwann cell GFAP expression increases in axonal neuropathies. J Neurol Sci 1991;102:177-183.
14. Miscio G, Pisano F, Mora G, Mazzini L. Motor neuron disease: usefulness of transcranial magnetic stimulation in improving the diagnosis. Clin Neurophysiol 1999;110:975-981. (Pubitemid 29281700)
15. Nobile Orazio E, Cappellari A, Priori A. Multifocal motor neuropathy: current concepts and controversies. Muscle Nerve 2005;31:663-680. (Pubitemid 40734675)
16. Norgren N, Sundström P, Svenningsson A, Rosengren L, Stigbrand T, Gunnarsson M. Neurofilament and glial fibrillary acidic protein in multiple sclerosis. Neurology 2004;1586-1590. (Pubitemid 39507573)
17. Notturno F, Caporale CM, De Lauretis A, Uncini A. Glial fibrillary acidic protein: a marker of axonal Guillain Barré syndrome and outcome. Muscle Nerve 2008;38:899-903. (Pubitemid 351915325)
18. O'Brien MD. Aids to the examination of the peripheral nervous system. Edinburgh: W.B. Saunders (on behalf of the Guarantors of Brain); 2000.
19. Olney RK, Lewis RA, Putnam TD, Campellone JV. Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve 2003;27:117-121. (Pubitemid 36083455)
20. Pakiam AS, Parry GJ. Multifocal motor neuropathy without overt conduction block. Muscle Nerve 1998;21:243-245. (Pubitemid 28079746)
21. Petzold A, Keir G, Green AJE, Giovannoni G, Thompson EJ. An ELISA for glial fibrillary acidic protein. J Immunol Methods 2004;287:169-177. (Pubitemid 38510218)
22. Quattrini A, Previtali S, Feltri ML, Canal N, Nemni R, Wrabetz L. Beta 4 integrin and other Schwann cell markers in axonal neuropathy. Glia 1996;17:294-306. (Pubitemid 26309422)
23. Slee M, Selvan A, Donaghy M. Multifocal motor neuropathy: the diagnostic spectrum and response to treatment. Neurology 2007;69:1680-1687. (Pubitemid 350287124)
24. Taylor BV, Dyck PJ, Engelstad J, Gruener G, Grant I, Dyck PJ. Multifocal motor neuropathy: pathologic alterations at the site of conduction block. J Neuropathol Exp Neurol 2004;63:129-137. (Pubitemid 38174778)
25. Triolo D, Dina G, Lorenzetti I, Malaguti M, Morana P, Del Carro U, et al. Loss of glial fibrillary acidic protein (GFAP) impairs Schwann cell proliferation and delays nerve regeneration after damage. J Cell Sci 2006;119:3981-3993. (Pubitemid 44650871)
26. Van Asseldonk JT, Van den Berg LH, Van den Berg-Vos RM, Wieneke GH, Wokke JH, Franssen H. Demyelination and axonal loss in multifocal motor neuropathy: distribution and relation to weakness. Brain 2003;126:186-198. (Pubitemid 36068569)